Slingshot members are tracking this event:
AbbVie 's (ABBV) Phase 3 Trial Evaluating Veliparib (ABT-888) in Treatment of Patients with Ovarian Cancer Expected to Conclude in January 2019
Slingshot Insights Explained
Nov 10, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Veliparib, Ovarian Cancer